Â鶹ֱ²¥app

Bipolar Disorder and Major Depression: Appraisal for Alcohol or Chemical Substance Use

INACTIVE REVIEW: This measure review is older than five years.

Percentage of patients with depression or bipolar disorder with evidence of an initial assessment that includes an appraisal for alcohol or chemical substance use.

Date Reviewed: November 19, 2017
Do Not Support: Uncertain Validity
    Group/Practice Individual Clinician

Measure Info

MIPS 367 CMS 367
Measure Type
Process
Measure Steward
Center for Quality Assessment and Improvement in Mental Health
Clinical Topic Area
Depression
Care Setting
Outpatient
Data Source
Electronic Health Records

ACP does not support QPP measure 367: "Bipolar Disorder and Major Depression: Appraisal for Alcohol or Chemical Substance Abuse." It is clinically important to screen patients diagnosed with bipolar disorder and major depression for substance abuse; however, measure developers did not provide adequate information to appropriately assess the measure. Additionally, developers cite outdated evidence to form the basis of the measure. It is unclear whether substance use appraisal alone without documentation of an appropriate treatment plan will significantly improve clinical outcomes. Furthermore, the measure specifications do not identify a validated assessment tool. Moreover, it is unclear if the denominator should include patients with pre-existing substance use diagnoses. Finally, CMS does not provide a pre-testing analysis of this measure and electronic data capture may be disproportionately high for some clinicians.